Clinical Trials Browser

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Endometrial Stromal, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT05580588 2025-06-13

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Phase 2 Terminated

14 enrolled 8 charts

Sarcoma

Liposarcoma

NCT02846987 2025-06-05

Study of Abemaciclib in Dedifferentiated Liposarcoma

Phase 2 Active not recruiting

33 enrolled

Sarcoma

Liposarcoma, Sarcoma

NCT03719430 2025-04-29

APX005M and Doxorubicin in Advanced Sarcoma

Phase 2 Active not recruiting

27 enrolled

Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

Clinical Trials

DOSa

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

TRABEPIO

PROSARC-1

PROSARC-2

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

TAIS

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

NeoSarc

TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

CDK4i

A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

PERELI

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Study of Abemaciclib in Dedifferentiated Liposarcoma

APX005M and Doxorubicin in Advanced Sarcoma